“Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In’l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan

Yu-Chun Lie

“Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In’l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan

Electrical and Computer Engineering

Research output: Contribution to conference › Paper › peer-review

Original language	English
State	Published - 2019

Fingerprint

Dive into the research topics of '“Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In’l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan'. Together they form a unique fingerprint.

Cite this

@conference{60eab305e4e848d4945e07e5663cea95,

title = "“Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In{\textquoteright}l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan",

author = "Yu-Chun Lie",

year = "2019",

language = "English",

}

“Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In’l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan. / Lie, Yu-Chun.

2019.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - “Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In’l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan

AU - Lie, Yu-Chun

PY - 2019

Y1 - 2019

M3 - Paper

ER -